The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies

Paediatric Anaesthesia

Volumn 17, Issue 8, 2007, Pages 789-792

  Simic, Dusica ^a   Milojevic, Irina ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

Anesthesia; Children; Hemophilia with antibodies

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; FENTANYL; PANCURONIUM; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SEVOFLURANE; THIOPENTAL;

ADOLESCENT; AORTA VALVE REGURGITATION; APPENDECTOMY; ARTICLE; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD ANALYSIS; BLOOD CELL COUNT; CASE REPORT; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; DRUG DOSE REDUCTION; HEMARTHROSIS; HEMOPHILIA A; HEPATITIS C; HUMAN; JOINT CONTRACTURE; MALE; MENTAL DISEASE; MITRAL VALVE REGURGITATION; OBESITY; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME; SYNOVECTOMY; THROMBOSIS;

ADOLESCENT; APPENDECTOMY; CHOLECYSTECTOMY; FACTOR VIIA; HEMOPHILIA A; HUMANS; INTRAOPERATIVE CARE; MALE;

EID: 34347250842     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02220.x     Document Type: Article

References (22)

1. Leblebisatan G, Sasmaz I. A successful use of recombinant factorVIIa in-patient with inhibitors, for bilateral cataract operation and circumcision. Haemophilia 2006 12 : 187 189.
2. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the profhylaxis of bleeding in various surgical procedures in haemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000 26 : 425 432.
3. Lusher JM. First and second-generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy and inhibitor development. Semin Thromb Hemost 2002 28 : 273 276.
4. Lollar P, Healey JF, Barrow RT et al. Factor VIII inhibitors. Adv Exp Med Biol 2001 489 : 65 73.
5. Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Hemost 2003 29 : 585 594.
6. Weiskopf RB. Current concept of hemostasis. Anesthesiology 2004 100 : 722 730.
7. Midathada MV, Mehta P, Waner M et al. Recombinant Factor VIIa in the treatment of bleeding. Am J Clin Pathol 2004 121 : 124 137.
8. Hvid I, Rodrigues-Merchan EC. Orthopaedic surgery in haemophilic patients with inhibitors: an overview. Haemophilia 2002 8 : 288 291.
9. Israels SJ. Factor VII deficiency. Available at: http://www.emedicine. com/ped/topic3041.htm (accessed on 28 June 2005).
10. Hoffman M, Monroe DMIII. The action of high-dose factor VIIa in cell-based model of hemostasis. Semin Hematol 2001 38 (Suppl. 12 6 9.
11. O'Connell N, McMahon C, Smith J et al. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors. Br J Haematol 2002 116 : 632 635.
12. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synoviectomy. Lancet 1988 2 : 1193.
13. Ingerslev J, Feldstedt M, Sindet-Pedersen D. Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII. Lancet 1991 338 : 831 832.
14. Ingerslev J, Feldstedt M, Gastineau D. et al. Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 1996 26 : 118 123.
15. Nakamura M., Terashima K, Takashima Y et al. Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in hemophilia A patient with inhibitors. Rinsho Ketsueki, 2002 43 : 183 188.
16. Jackson S. Facts about hemophilia and NovoSeven Coagulation Factor VIIa (Recombinant). Available at: http://press.novonordisk-us.com (accessed on August 2006).
17. Chin C. Recombinant activated factor VII. Pediatr Anesth 2006 16 : 907 909.
18. Gerotziafas GT, Zervas K, Arzoglou P. et al. On the mechanism of action of recombinant activated factor VII administrated to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation. Br J Haemat 2002 117 : 705 708.
19. Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2003 26 : 385 391.
20. Yoshioka A, Nishio K, Shima M. Thromboelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII. Haemostasis 1996 26 : 139 142.
21. Smith OP. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors. Pathophysiol Haemost Thromb 2002 32 (Suppl. 1 22 25.
22. Shapiro A. Inhibitor treatment: state of the art. Dis Mon 2003 49 : 22 38.